Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.

[1]  P. Grant.  Diabetes mellitus as a prothrombotic condition , 2007, Journal of internal medicine.

[2]  T. Imaizumi,et al.  Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. , 2007, Cardiovascular & hematological agents in medicinal chemistry.

[3]  Shaun P Jackson,et al.  The growing complexity of platelet aggregation. , 2007, Blood.

[4]  V. Morsch,et al.  NTPDase and 5′-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis , 2007, Molecular and Cellular Biochemistry.

[5]  V. Morsch,et al.  Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory processes , 2007, The FEBS journal.

[6]  B. Materson,et al.  Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. , 2007, Atherosclerosis.

[7]  M. Lagarde,et al.  In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  D. Wagner,et al.  Platelet adhesion receptors and their ligands in mouse models of thrombosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[9]  V. Morsch,et al.  Enhanced NTPDase and 5′-nucleotidase activities in diabetes mellitus and iron-overload model , 2007, Molecular and Cellular Biochemistry.

[10]  M. Hermans,et al.  DIABETES AND THE ENDOTHELIUM , 2007, Acta clinica Belgica.

[11]  V. Morsch,et al.  Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon-β , 2007 .

[12]  T. Pawełczyk,et al.  Alterations of Adenine Nucleotide Metabolism and Function of Blood Platelets in Patients With Diabetes , 2007, Diabetes.

[13]  Tricia Smith,et al.  A pilot study showing an association between platelet hyperactivity and the severity of peripheral arterial disease , 2007, Platelets.

[14]  A. Laggner,et al.  Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS , 2006, Journal of thrombosis and haemostasis : JTH.

[15]  S. Kunapuli,et al.  Nucleotide receptor signaling in platelets , 2006, Journal of thrombosis and haemostasis : JTH.

[16]  S. Susen,et al.  From normal to pathological hemostasis , 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[17]  P. Hjemdahl,et al.  Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty , 2006, Diabetes & vascular disease research.

[18]  S. Robson,et al.  Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. , 2006, Blood cells, molecules & diseases.

[19]  M. Hoylaerts,et al.  The platelet ATP and ADP receptors. , 2006, Current pharmaceutical design.

[20]  C. Gachet.  Regulation of platelet functions by P2 receptors. , 2006, Annual review of pharmacology and toxicology.

[21]  G. Boden,et al.  Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects , 2006, Platelets.

[22]  Andrew J. Johnson,et al.  Adenine nucleotide metabolism in human blood – important roles for leukocytes and erythrocytes , 2005, Journal of thrombosis and haemostasis : JTH.

[23]  M. J. Broekman,et al.  Role of CD39 (NTPDase-1) in Thromboregulation, Cerebroprotection, and Cardioprotection , 2005, Seminars in thrombosis and hemostasis.

[24]  K. Ley,et al.  Targeted Disruption of cd73/Ecto-5′-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response , 2004, Circulation research.

[25]  V. Morsch,et al.  NTPDase and 5'-nucleotidase activities in rats with alloxan-induced diabetes. , 2004, Diabetes research and clinical practice.

[26]  M. Lagarde,et al.  Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. , 2004, Diabetes.

[27]  A. Marcus,et al.  Heterologous cell–cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase‐1) , 2003, Journal of thrombosis and haemostasis : JTH.

[28]  V. Morsch,et al.  Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. , 2003, Thrombosis research.

[29]  J. Sévigny,et al.  Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. , 2002, Blood.

[30]  A. Sobol,et al.  The role of platelets in diabetes-related vascular complications. , 2000, Diabetes research and clinical practice.

[31]  K. Kugiyama,et al.  Rapid Change of Platelet Aggregability in Acute Hyperglycemia , 2000, Thrombosis and Haemostasis.

[32]  D. Lominadze,et al.  In vivo platelet thrombus formation in microvessels of spontaneously hypertensive rats. , 1997, American journal of hypertension.

[33]  A. Marcus,et al.  Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  K. Chan,et al.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity. , 1986, Analytical biochemistry.

[35]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[36]  M. Cattaneo.  ADP receptors: inhibitory strategies for antiplatelet therapy. , 2006, Drug news & perspectives.

[37]  I. Russo,et al.  Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. , 2002, Thrombosis research.

[38]  T. Emanuelli,et al.  ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. , 1996, Platelets.